Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs

Journal of Peptide Science

Volumn 17, Issue 12, 2011, Pages 812-817

  Nan, Yong Hai ^a   Park, Il Seon ^a,b   Hahm, Kyung Soo ^a,b   Shin, Song Yub ^a,b  

^a Chosun University   (South Korea)

^b Chosun University College of Medicine   (South Korea)

Author keywords

Antimicrobial activity; Bactericidal mechanism; Cell penetrating peptide; LPS neutralizing activity; pVEC

Indexed keywords

ADENOSINE PHOSPHATE; CELL PENETRATING PEPTIDE; CELL PENETRATING PEPTIDE PVEC; ION CHANNEL; LIPOPOLYSACCHARIDE; LIPOSOME; MAGAININ 2; NITRIC OXIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; HEMOLYSIS; HUMAN; HUMAN CELL; MACROPHAGE; MEMBRANE DEPOLARIZATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CELL MEMBRANE; CELL-PENETRATING PEPTIDES; HEMOLYTIC AGENTS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PEPTIDES; PERMEABILITY; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

ANURA; BACTERIA (MICROORGANISMS); MURINAE; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 81155123201     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1408     Document Type: Article

References (39)

1. Elmquist A, Lindgren M, Bartfai T, Langel U. VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell Res. 2001; 269: 237-244.
2. Elmquist A, Langel U. In vitro uptake and stability study of pVEC and its all-D analog. Biol. Chem. 2003; 384: 387-393.
3. Hancock RE. Peptide antibiotics. Lancet 1997; 349: 418-422.
4. Nekhotiaeva N, Elmquist A, Rajarao GK, Hallbrink M, Langel U, Good L. Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J. 2004; 18: 394-396.
5. Palm C, Netzereab S, Hällbrink M. Quantitatively determined uptake of cell penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 2006; 27: 1710-1716.
6. Khandelia H, Kaznessis YN. Cation-π interactions stabilize the structure of the antimicrobial peptide indolicidin near membranes: molecular dynamics simulations. J. Phys. Chem. B 2007; 111: 242-250.
7. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
8. Bowdish DM, Davidson DJ, Scott MG, Hancock RE. Immunomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother. 2005; 49: 1727-1732.
9. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990; 35: 161-214.
10. Zhu WL, Lan H, Park Y, Yang ST, Kim JI, Park IS, You HJ, Lee JS, Park YS, Kim Y, Hahm KS, Shin SY. Effects of Pro→peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide. Biochemistry 2006; 45: 13007-13017.
11. Zhu WL, Hahm KS, Shin SY. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1. J. Pept. Sci. 2009; 15: 569-575.
12. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 2000; 44: 2086-2092.
13. Barlett GR. Phosphorus assay in column chromatography. J. Biol. Chem. 1959; 234: 466-468.
14. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988; 48: 4827-4833.
15. Park KH, Nan YH, Park Y, Kim JI, Park IS, Hahm KS, Shin SY. Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides. Biochim. Biophys. Acta 2009; 1788: 1193-1203.
16. 15N]nitrate in biological fluids. Anal. Biochemistry 1982; 126: 131-138.
17. Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005; 280: 12316-12329.
18. Fázio MA, Jouvensal L, Vovelle F, Bulet P, Miranda MT, Daffre S, Miranda A. Biological and structural characterization of new linear gomesin analogues with improved therapeutic indices. Biopolymers 2007; 88: 386-400.
19. Zhu WL, Song YM, Park Y, Park KH, Yang ST, Kim JI, Park IS, Hahm KS, Shin SY. Substitution of the leucine zipper sequence in melittin with peptoid residues affects self-association, cell selectivity, and mode of action. Biochim. Biophys. Acta 2007; 1768: 1506-1517.
20. Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. Int. J. Antimicrob. Agents 2008; 32: 130-138.
21. Solanas C, de la Torre BG, Fernández-Reyes M, Santiveri CM, Jimenez MA, Rivas L, Jiménez AI, Andreu D, Cativiela C. Therapeutic index of gramicidin S is strongly modulated by d-phenylalanine analogues at the β-turn. J. Med. Chem. 2009; 52: 664-674.
22. Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY. Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich α-helical model antimicrobial peptide and its diastereomeric peptides. Peptides 2010; 31: 1251-1261.
23. Dathe M, Wieprecht T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta. 1999; 1462: 71-87.
24. Uematsu N, Matsuzaki K. Polar angle as a determinant of amphipathic α-helix-lipid interactions: a model peptide study. Biophys. J. 2000; 79: 2075-2083.
25. Giangaspero A, Sandri L, Tossi A. Amphipathic α-helical antimicrobial peptides. Eur. J. Biochem. 2001; 268: 5589-5600.
26. Dathe M, Meyer J, Beyermann M, Maul B, Hoischen C, Bienert M. General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides. Biochim. Biophys. Acta. 2002; 1558: 171-186.
27. Kim YS, Cha HJ. Disperse distribution of cationic amino acids on hydrophilic surface of helical wheel enhances antimicrobial peptide activity. Biotechnol. Bioeng. 2010; 107: 216-223.
28. Kim S, Kim SS, Lee BJ. Correlation between the activities of α-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times. Peptides 2005; 26: 2050-2056.
29. Yang ST, Shin SY, Hahm KS, Kim JI. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities. Int. J. Antimicrob. Agents 2006; 27: 325-330.
30. Nan YH, Lee SH, Kim HJ, Shin SY. Mammalian cell toxicity and candidacidal mechanism of Arg- or Lys-containing Trp-rich model antimicrobial peptides and their D-enantiomeric peptides. Peptides 2010; 31: 1826-1831.
31. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1998; 1376: 391-400.
32. Oren Z, Shai Y. Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 1998; 47: 451-463.
33. Heller WT, Waring AJ, Lehrer RI, Harroun TA, Weiss TM, Yang L, Huang HW. Membrane thinning effect of the β-sheet antimicrobial protegrin. Biochemistry 2000; 39: 139-145.
34. Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998; 244: 253-257.
35. Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. USA 2000; 97: 8245-8250.
36. Kobayashi S, Chikushi A, Tougu S, Imura Y, Nishida M, Yano Y, Matsuzaki K. Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry 2004; 43: 15610-15616.
37. Matsuzaki K, Yoneyama S, Miyajima K. Pore formation and translocation of melittin. Biophys. J. 1997; 73: 831-838.
38. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2003; 348: 1546-1554.
39. Hancock RE, Scott MG. The role of antimicrobial peptides in animal defenses, Proc. Natl. Acad. Sci. USA 2000; 97: 8856-8861.